[Antipyretics in intensive care patients]. - Wikidata - awgldk - TriplyDB

[Antipyretics in intensive care patients].

[Antipyretics in intensive care patients].

http://www.wikidata.org/entity/Q40062998

about

[Antipyretics in intensive care patients].

http://www.wikidata.org/entity/Q40062998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

[Antipyretics in intensive care patients].

@en

type

label

[Antipyretics in intensive care patients].

@en

prefLabel

[Antipyretics in intensive care patients].

@en

P1433

Q40062998-F55288B6-8F2A-48CA-93A9-4CA54C9096DC

P1476

Q40062998-021BA3FC-A982-4999-8358-697BC3896677

P2093

Q40062998-17BDB4A0-F635-4618-9D94-FBCFB396F8CF

Q40062998-5019B226-50C2-41A7-8603-CFC6582B3D28

P2860

Q40062998-02AA8546-1ABE-4ABE-AA50-3AA1460F6023

Q40062998-06049DD4-D9A0-4EE8-86F0-4B6E7E055C06

Q40062998-09C428D4-B0E6-4349-9393-87D5F3541F19

Q40062998-0F39277F-4DE1-407C-8D8A-CD058429AEFD

Q40062998-1BA9D99D-BE12-4C19-8148-1AD8E7F8675A

Q40062998-21E7560C-740E-4707-ACFB-F7BDFF8A3651

Q40062998-228A28CB-27A7-4E71-83E6-A6A76C233067

Q40062998-23B95D68-39C7-4BC1-9ABD-956447F2F0E2

Q40062998-28D8E235-E898-4614-BF66-9A413AB0DCE8

Q40062998-29B3AECC-3D4C-494B-9064-37EAFAE5C0BE

P2888

Q40062998-E8E21F61-DD93-47E3-BC2C-8A63AA41F644

P304

Q40062998-21193EDA-D081-431E-B244-2CF3574F36EB

P31

Q40062998-051bc0b0-617b-4929-a7c0-28ba8d082d2b

Q40062998-EF7B8AFD-99E7-4EFD-A190-CCD45A91D448

P356

Q40062998-DEAE6A49-FF4E-4D66-AE3B-F510A2954C68

P407

Q40062998-D07CF1D1-857A-44CC-A66F-9FEA494C22C0

P433

Q40062998-6360DCF6-324D-48BA-B18F-E89D4FB5D709

P478

Q40062998-334B8510-DAF3-4EFF-AC6E-37278EE83EBC

P577

Q40062998-D9E2FAA2-2797-4E90-A1C6-279888644699

P698

Q40062998-6B54D8FC-76C9-4893-A45F-1FA84D5D0B9E

P356

S00101-017-0301-9

P1433

P1476

[Antipyretics in intensive care patients].

@en

P2093

A Leffler

http://www.w3.org/2001/XMLSchema#string

A Simon

http://www.w3.org/2001/XMLSchema#string

P2860

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study

Acetaminophen has limited antipyretic activity in critically ill patients.

Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.

A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults

Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial.

Effect of a fever control protocol-based strategy on ventilator-associated pneumonia in severely brain-injured patients

Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial.

P2888

s00101-017-0301-9

P304

511-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00101-017-0301-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28364306

http://www.w3.org/2001/XMLSchema#string